https://scholars.lib.ntu.edu.tw/handle/123456789/494985
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Park K | en_US |
dc.contributor.author | Tan E.-H | en_US |
dc.contributor.author | Zhang L | en_US |
dc.contributor.author | Hirsh V | en_US |
dc.contributor.author | O'Byrne K | en_US |
dc.contributor.author | Boyer M | en_US |
dc.contributor.author | CHIH-HSIN YANG | en_US |
dc.contributor.author | Mok T | en_US |
dc.contributor.author | Kim M | en_US |
dc.contributor.author | Paz-Ares L. | en_US |
dc.creator | Paz-Ares L.;Kim M;Mok T;Chih-Hsin Yang;Boyer M;O'Byrne K;Hirsh V;Zhang L;Tan E.-H;Park K | - |
dc.date.accessioned | 2020-05-26T09:26:47Z | - |
dc.date.available | 2020-05-26T09:26:47Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1556-0864 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85037604373&doi=10.1016%2fS1556-0864%2816%2930250-7&partnerID=40&md5=44f300d7099cc9c659bd825642f4ab3a | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/494985 | - |
dc.publisher | Elsevier Inc | - |
dc.relation.ispartof | Journal of Thoracic Oncology | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | afatinib; alanine aminotransferase; epidermal growth factor receptor; gefitinib; acne; advanced cancer; alanine aminotransferase blood level; Article; Asian; brain metastasis; controlled study; diarrhea; drug efficacy; drug response; drug safety; drug treatment failure; drug withdrawal; EGFR gene; female; gene deletion; gene mutation; human; major clinical study; male; non small cell lung cancer; open study; overall survival; phase 2 clinical trial; priority journal; progression free survival; prospective study; randomized controlled trial; rash; side effect; tumor volume | - |
dc.title | 140PD: LUX-Lung 7: A Phase IIb, global, randomised, open-label trial of afatinib vs gefitinib as first-line treatment for patients (pts) with advanced non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/S1556-0864(16)30250-7 | - |
dc.identifier.scopus | 2-s2.0-85037604373 | - |
dc.relation.pages | S117-S118 | - |
dc.relation.journalvolume | 11 | - |
dc.relation.journalissue | 4 | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Cancer Administration and Coordination Center | - |
crisitem.author.dept | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.orcid | 0000-0002-5586-5138 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。